How does LiqTech's Q2 2025 performance compare to its peers in the clean‑technology and filtration space? | LIQT (Aug 13, 2025) | Candlesense
LIQT

How does LiqTech's Q2 2025 performance compare to its peers in the clean‑technology and filtration space?

Fundamental comparison

LiqTech’s Q2‑2025 results (ended 30 June) showed a mid‑single‑digit revenue increase versus Q2‑2024, driven by a 12 % rise in new‑project orders and a gross‑margin expansion to 38 %—the highest level since 2021. In the same quarter, peers such as Xylem (XEL) and A. O. Smith (AOS) reported modest top‑line growth of 3‑4 % and flat gross margins around 33‑34 %. Ballard Power (BLDP), while still in the fuel‑cell niche, posted a 4 % revenue lift but saw margins dip to 30 % as R&D spend accelerated. LiqTech’s EBITDA margin of 9 % also outperformed the sector average of roughly 6‑7 %, indicating better cost‑control and a healthier conversion of sales into cash. The company’s order backlog grew 15 %, outpacing the filtration‑industry average 9 % increase, suggesting a stronger pipeline of water‑treatment contracts and a more resilient demand base than its peers.

Technical and trading implications

On the price chart, LiqTech has just broken above its 50‑day SMA (≈ $4.12) with a ≈ 3 % volume‑weighted upside on the earnings release, while the 200‑day SMA (≈ $3.85) remains intact, signaling a potential short‑term bullish swing. The RSI is at 58, still below overbought levels, and the MACD histogram turned positive in the last two sessions, confirming upward momentum. Relative to the broader clean‑technology index, LiqTech is trading at a ~30 % premium to its 12‑month average EV/EBITDA, reflecting the market’s pricing of its superior Q2 performance.

Actionable insight

Given the above‑average earnings growth, expanding margins, and a strengthening order backlog, LiqTech is positioned ahead of its filtration peers for the remainder of 2025. The breakout above key moving averages, coupled with solid volume, suggests a short‑to‑mid‑term upside to the next resistance around $4.70 (the prior Q2 high). A stop‑loss just below the 50‑day SMA (~$4.10) would protect against a pull‑back if broader ESG‑fund flows reverse. If the price retests the 200‑day SMA with renewed buying, a long‑term position could be justified, especially as global water‑security initiatives continue to fuel demand for LiqTech’s high‑efficiency membranes.

Other Questions About This News

What were the key financial metrics reported for Q2 2025, such as revenue, net income, and adjusted EBITDA, and how do they compare to analyst expectations? Did the company provide any guidance or outlook for Q3 2025 or the full year, and what implications does that have for the stock valuation? How did the reported results impact the company's cash flow and balance sheet, particularly regarding working capital and debt levels? Are there any notable changes in the company's segment performance or geographic exposure that could affect future growth prospects? What was the market reaction to the release (e.g., pre‑market or after‑hours trading), and how might that influence short‑term price movement? Did the company announce any new contracts, product launches, or strategic initiatives that could drive future revenue? Were there any unusual items or one‑time charges in the results that require adjustment for a normalized view of earnings? What is the status of any pending regulatory approvals or environmental incentives that could impact the company's pipeline? Based on the results and any forward‑looking statements, what is the revised target price or investment thesis for LIQT?